Keros Therapeutics Inc (KROS)
60.35
-2.72
(-4.31%)
USD |
NASDAQ |
Nov 14, 16:00
60.35
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Shareholders Equity (Quarterly): 532.84M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 532.84M |
| June 30, 2024 | 420.92M |
| March 31, 2024 | 453.95M |
| December 31, 2023 | 332.21M |
| September 30, 2023 | 295.84M |
| June 30, 2023 | 326.26M |
| March 31, 2023 | 354.98M |
| December 31, 2022 | 277.42M |
| September 30, 2022 | 241.02M |
| June 30, 2022 | 211.21M |
| Date | Value |
|---|---|
| March 31, 2022 | 223.49M |
| December 31, 2021 | 243.17M |
| September 30, 2021 | 218.48M |
| June 30, 2021 | 235.66M |
| March 31, 2021 | 248.37M |
| December 31, 2020 | 261.72M |
| September 30, 2020 | 130.76M |
| June 30, 2020 | 141.36M |
| March 31, 2020 | 50.86M |
| December 31, 2019 | 0.495M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.495M
Minimum
Dec 2019
532.84M
Maximum
Sep 2024
260.05M
Average
245.77M
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Scholar Rock Holding Corp | 133.62M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 579.27M |
| Total Liabilities (Quarterly) | 46.44M |
| Current Ratio | 19.03 |